Tag: FDA generic drug surveillance
Post-Market Surveillance: How the FDA Monitors Generic Drugs After Approval
The FDA monitors generic drugs after approval using real-time data, adverse event reports, and AI tools to catch safety issues that clinical trials miss. With 90% of prescriptions filled with generics, post-market surveillance is critical to ensure ongoing safety and effectiveness.
Read More